|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-12-19
|
|
pubmed:abstractText |
To compare antibody responses to 23-valent pneumococcal vaccine (Pneumovax) in controls and patients with established rheumatoid arthritis (RA) treated with TNF blockers, methotrexate (MTX) or a combination of both.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/23-valent pneumococcal capsular...,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Pneumococcal Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1462-0324
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
106-11
|
|
pubmed:dateRevised |
2007-9-6
|
|
pubmed:meshHeading |
pubmed-meshheading:16287919-Adolescent,
pubmed-meshheading:16287919-Adult,
pubmed-meshheading:16287919-Aged,
pubmed-meshheading:16287919-Aged, 80 and over,
pubmed-meshheading:16287919-Anti-Inflammatory Agents,
pubmed-meshheading:16287919-Antibodies, Monoclonal,
pubmed-meshheading:16287919-Antibody Formation,
pubmed-meshheading:16287919-Antirheumatic Agents,
pubmed-meshheading:16287919-Arthritis, Rheumatoid,
pubmed-meshheading:16287919-Case-Control Studies,
pubmed-meshheading:16287919-Drug Combinations,
pubmed-meshheading:16287919-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16287919-Female,
pubmed-meshheading:16287919-Humans,
pubmed-meshheading:16287919-Immunoglobulin G,
pubmed-meshheading:16287919-Male,
pubmed-meshheading:16287919-Methotrexate,
pubmed-meshheading:16287919-Middle Aged,
pubmed-meshheading:16287919-Pneumococcal Infections,
pubmed-meshheading:16287919-Pneumococcal Vaccines,
pubmed-meshheading:16287919-Prednisolone,
pubmed-meshheading:16287919-Receptors, Tumor Necrosis Factor
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
|
|
pubmed:affiliation |
Department of Rheumatology, Lund University Hospital, Kioskgatan 3, S-221 85 Lund, Sweden. meliha.crnkic@reum.lu.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
